Valeant Pharmaceuticals International, Inc. (VRX)

NYSE - NYSE Real Time Price. Currency in USD
27.72+0.87 (+3.24%)
At close: 4:01 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close26.85
Bid27.73 x 3000
Ask27.79 x 100
Day's Range26.46 - 27.84
52wk Range18.55 - 206.51
1y Target EstN/A
Market Cap9.63B
P/E Ratio (ttm)-9.44
Avg Vol (3m)25,911,271
Dividend & Yield0.00 (0.00%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Senator Tom Coburn on drug pricing and political gridlock
    Editor's Pick
    Nicole Sinclair7 hours ago

    Senator Tom Coburn on drug pricing and political gridlock

    When it comes to hot-button political topics, soaring drug prices are at the top of the list. Companies from Mylan (MYL) to Valeant (VRX) have come under fire for soaring prices, and Tom Coburn, former Republican Senator from Oklahoma, says more medical innovation is necessary to keep this from happening. “There are a lot of products that aren’t available to American citizens because of our regulatory environment,” Coburn said.

  • Investopedia8 hours ago

    Wealth Preservation: "All I Know Is That I Know Nothing"

    Investors can derive great value from humility. By keeping the adage "all I know is that I know nothing" in mind, they can invest more effectively.

  • Barrons.com2 days ago

    Investing for the Next 100 Years

    After a decade of working with family offices of all sizes, types, and means, Ned Dane, head of the OppenheimerFunds’ Private Client Group, says that in the end their goals are all the same: to generate income for families for hundreds of years. One long-term investment that Dane offers his clients is catastrophe bonds, which are a fixed-income form of reinsurance, traditionally the way the insurance industry spreads its bets to other insurance companies.